Bioavailability and pharmacokinetics of oxytetracycline in cultured rainbow trout following intramusicular administration

被引:0
|
作者
Dagoglu, G [1 ]
Turel, L
Yilmaz, O
Yarsan, E
Oto, G
Kankaya, E
机构
[1] Univ Yununcu Yil, Fac Med Vet, Dept Pharmacol, TR-65080 Van, Turkey
[2] Univ Yununcu Yil, Fac Med Vet, Dept Fisheries & Aquaculture, TR-65080 Van, Turkey
[3] Ankara Univ, Fac Vet Med, Dept Pharmacol & Toxicol, TR-06300 Ankara, Turkey
来源
INDIAN VETERINARY JOURNAL | 2004年 / 81卷 / 09期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Aquaculture production of rainbow trout has increased in Turkey in the recent years. There is great concern over the use of drugs for fish production. Bacterial diseases, if untreated, may lead to great economic losses in the form of fish mortality and reduced growth. Thus aquafarming uses a wide variety of drugs for prevention and treatment of disease in cultured fish. Among these drugs, oxytetracycline (OTC) is a broad-spectrum antibiotic used for the treatment of a variety diseases including vibriosis, furunculosis, enteric redmouth, bacterial haemorrhagic septicemia, fin rot, gill disease columnaris and edwardsiellosis (Black et al., 1991; Unb, 1996). There is a paucity of information on the pharmacokinetics of OTC in farmed fish. The pharmacokinetics of OTC may be changed by parameters such as fish species, age, water temperature and salinity, route of administration and other conditions. Therefore the present study was performed to investigate the pharmacokinetics, i.e. absorption, distribution and elimination, of OTC in rainbow trout (Oncorhynchus mykiss) after intra-muscular administration.
引用
收藏
页码:989 / 992
页数:4
相关论文
共 50 条
  • [41] PHARMACOKINETICS AND RENAL CLEARANCE OF OXYTETRACYCLINE IN PIGLETS FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION
    MEVIUS, DJ
    VELLENGA, L
    BREUKINK, HJ
    NOUWS, JFM
    VREE, TB
    DRIESSENS, F
    VETERINARY QUARTERLY, 1986, 8 (04) : 274 - 284
  • [42] Research on Bacteraemia in Cultured Rainbow Trout
    A. Panebianco
    A. Giuffrida
    F. Conte
    G. Ziino
    A. Minniti
    L. Iannuzzi
    Veterinary Research Communications, 2004, 28 : 261 - 263
  • [43] Comparative pharmacokinetics and bioavailability of oxytetracycline in giant tiger prawn
    Sangrungruang, K
    Chotchuang, A
    Ueno, R
    FISHERIES SCIENCE, 2004, 70 (03) : 467 - 472
  • [44] BIOAVAILABILITY, DISPOSITION AND PHARMACOKINETICS OF C-14 ORMETOPRIM IN RAINBOW-TROUT (SALMO-GAIRDNERI)
    DROY, BF
    GOODRICH, MS
    LECH, JJ
    KLEINOW, KM
    XENOBIOTICA, 1990, 20 (02) : 147 - 157
  • [45] PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF CYCLOSPORINE FOLLOWING INTRAVENOUS AND ABOMASAL ADMINISTRATION TO SHEEP
    CHARLES, BG
    FILIPPICH, LJ
    PASS, MA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (09) : 821 - 824
  • [46] Pharmacokinetics and Absolute Bioavailability of Mepolizumab Following Administration at Subcutaneous and Intramuscular Sites
    Ortega, Hector
    Yancey, Steve
    Cozens, Simon
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (01): : 57 - 62
  • [47] Pharmacokinetics and bioavailability of marbofloxacin in lambs following administration of intravenous, intramuscular and subcutaneous
    Altan, Feray
    Corum, Orhan
    Corum, Duygu Durna
    Atik, Orkun
    Uney, Kamil
    SMALL RUMINANT RESEARCH, 2018, 159 : 5 - 10
  • [48] Pharmacokinetics and bioavailability of ofloxacin following single intramuscular and subcutaneous administration in goats
    Yadav, Rajkumar Singh
    Garg, Satish Kumar
    INDIAN JOURNAL OF ANIMAL SCIENCES, 2016, 86 (07): : 764 - 766
  • [49] PHARMACOKINETICS AND BIOAVAILABILITY OF PIRETANIDE IN HEALTHY-VOLUNTEERS FOLLOWING INTRAMUSCULAR ADMINISTRATION
    TRENK, D
    WAGNER, F
    JAHNCHEN, E
    SPAHN, H
    MUTSCHLER, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (12): : 1382 - 1385
  • [50] Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats
    Kwak, Jae-Hwan
    Kim, Younghwa
    Staatz, Christine E.
    Baek, In-hwan
    XENOBIOTICA, 2021, 51 (07) : 811 - 817